Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
21
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Cross Asset Strategy
•
28 Apr 2017 05:42
EM Managers - Most Avoided Stocks
• The 830 stocks in the benchmark MSCI Emerging Market Index all represent legitimate investments for global EM active managers. Whilst publicly...
Steven Holden
Follow
338 Views
Share
bearish
•
Celltrion Inc
•
22 Apr 2017 02:17
The Disconnect Is Growing
Celltrion Inc (068270 KS) 's Inflectra, a biosimilar to Johnson & Johnson (JNJ US) 's Remicade, had little impact on the critical U.S. market...
Kemp Dolliver, CFA
605 Views
Share
bullish
•
Thematic (Sector/Industry)
•
09 Mar 2017 23:38
Alpha Generation from Share Buybacks in Korea (2017 YTD)
In this report, we have identified 26 stocks in the Korean stock market that have announced share buyback programs so far in 2017. These stocks...
Douglas Kim
Follow
1.3k Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Mar 2017 10:59
Update on the Put Back Option Clause for IPOs in the Korea Stock Market
This report is an update on the implementation of the "put-back option clause" for IPOs in the Korea Stock Market (for companies applying under the...
Douglas Kim
Follow
399 Views
Share
bullish
•
Celltrion Healthcare
•
03 Mar 2017 02:06
Celltrion Healthcare IPO - Summary on Last Week's IPO Roadshow in HK & Singapore
Celltrion Healthcare just completed the pre-IPO roadshows in Hong Kong and Singapore last week. The company officials met about 15 institutional...
Sanghyun Park
Follow
346 Views
Share
First
Previous
80
81
82
83
84
85
86
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x